Clinical & Biological Sample Database of Chinese Elderly Patients With

Status Recruiting

Clinical Trial Summary

The investigators aim to establish a clinical database and biobank for elderly patients with multiple diseases. The collected data will include demographic information, comorbidity characteristic, FRAIL scale, age-adjusted Charlson comorbidity index, relevant blood tests, the results of imaging examination, prescription of drugs, length of hospital stay, number of overall rehospitalizations and death. With this database, the investigators intend to formulate an individualized treatment strategy for these patients.

Clinical Trial Description

According to the China Health and Aging Tracking Survey, a significant proportion of elderly individuals aged over 65 suffer from two or more chronic diseases, with prevalence rates ranging from 22.5% to 47.5%. However, due to the decentralized storage of health data, lack of standardization, and collaboration barriers, it is challenging to make use of this information in a meaningful way.Therefore, there is an urgent need to overcome the technical challenges and build an intelligent diagnosis and treatment system for this vulnerable population. To achieve this goal, it is necessary to establish a clinical database and biobank that includes data on all elderly patients with multimorbidity. This will enable researchers to conduct clinical research on various factors, including clinical and biological predictors of adverse events such as emergency visits, strokes, heart failure, myocardial infarction, tumors, and acute chronic obstructive pulmonary disease. Additionally, the database will facilitate the development of systematic and individualized evaluation tools for elderly patients with multimorbidity, identify prognostic factors that improve short- and long-term outcomes, and enable the participation in multi-center trials at the national or international level. Ultimately, this effort will help establish clinical database and biobank data collection standards for future studies. ;

Study Design

Related Conditions & MeSH terms

Comorbidities and Coexisting Conditions
Frailty
Old Age; Debility

Clinical Trial Details

NCT number	NCT05797402
Study type	Observational
Source	Beijing Anzhen Hospital
Contact	Shao-ping Nie, MD,PhD
Phone	8613701186772
Email	spnie@ccmu.edu.cn
Status	Recruiting
Phase
Start date	January 1, 2013
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05059964` - Circuit Training and Aerobic Exercise Among Sedentary Elderly Population	N/A
Recruiting	`NCT04091152` - TIKeasy TAblet satisfaCtion (TikTac)
Recruiting	`NCT04938349` - Dual Task Perturbation Training for OAwMCI	N/A
Completed	`NCT04983602` - Physiotherapy Led Community Intervention for Older Adults Discharged From the Emergency Department	N/A
Recruiting	`NCT04851405` - Implementing an Evidence-based Exercise Program to Reduce Falls in Community-dwelling Older Adults (Otago)	N/A
Completed	`NCT04757454` - Performance Indicators of the SARC-F Questionnaire in Acute Care
Recruiting	`NCT06388434` - Protective Arm Balance Responses	N/A
Recruiting	`NCT04301713` - Multifactorial Study of the Relationship Between the Conditions of Life and the Incidence of Risk of Falling
Recruiting	`NCT04715581` - Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty	N/A
Completed	`NCT04297111` - Probiotic-Muscle Study	N/A
Completed	`NCT04165005` - Mindfulness-based Short Intervention for Seniors - Decentering Effects on Cognitive Functions and Psychological Distress	N/A
Completed	`NCT03134807` - The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
Completed	`NCT05287932` - Brief Physical Activity Intervention for Older People With Multimorbidity	N/A
Completed	`NCT04770259` - Pre-surgical Protocol for Frail Elderly People in Order to Reduce Hospitalization Days (APOPM).	N/A
Not yet recruiting	`NCT06352099` - Dietary Supplementation and Cognitive Functions in the Elderly	N/A
Not yet recruiting	`NCT04348539` - Older People Gait: Physiomechanics and Functionality	N/A
Recruiting	`NCT04856202` - ACP in Older Patients With Multimorbidity: a Randomized Pilot	N/A
Not yet recruiting	`NCT06353438` - Hydraulic Resistance and Older Adults	N/A
Not yet recruiting	`NCT05317338` - Multicomponent Exercises in Functional Performance and Cognitive Ability of Hospitalized Elderly	N/A
Recruiting	`NCT05175508` - Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms